https://www.selleckchem.com/pr....oducts/tegatrabetan.
Inclusion criteria for renal function was highly variable and ambiguous; creatinine 1.2-3.0mg/dL, creatinine clearance 20-60mL/min, and GFR 30-70mL/min. These results suggest highly variable inclusion/exclusion criteria for early phase CAR-T studies that may limit patient accessibility to therapy and emphasize the need for a standardized, evidence-based approach to patient enrollment. These results suggest highly variable inclusion/exclusion criteria for early phase CAR-T studies that may limit patient accessibility to
Like
Comment
Share
